When was the last time your company produced a printed catalog? You might want to consider the effectiveness of a printed catalog for certain regions such as in China. In Apr 2013, we polled Chinese cell culture researchers regarding what catalogs they used in the last month to purchase life science research products and whether it was in print…read more >
We asked 2,172 researchers around the world what they thought of the announcement that Thermo Fisher Scientific is acquiring Life Technologies. Less than 24 hours after the announcement roughly half of the participants (49%) were aware of the news. The fact that this news has spread this quickly is a testament to the considerable impact this merger is likely…read more >
Percepta Survey Finds Personnel, Reagent and Instrument Spending in Academic Research Labs Negatively Affected Both Prior to and Post Budget Sequester
CARLSBAD, CALIFORNIA – Though the U.S. Federal government implemented budget sequestration on March 1st, canceling $85 billion in budgetary resources across the Federal government for the remainder of the 2013 fiscal year, U.S. academic researchers spend on life science reagents and instruments decreased as early as October, 2012, according to Percepta’s recent benchmarking study.
The study objectives were to understand…read more >
Percepta: Epigenetics has certainly been a hot topic. We’re very glad to have a chance to speak with you and get your read on where the field is heading. Now that the field has had a chance to develop, can you give our readers a brief summary of what is now encompassed in the field of epigenetics?
PJ: Well that…read more >
China remains an attractive market for life science tools suppliers capable of taking advantage…read more >
Growing at an Attractive Rate, the Fluorescent Imaging Research Market Presents Promising Opportunities for New Product Development
Life Technologies Dominates the Market, while Abcam and BD Biosciences Maintain a Strong Presence.
Carlsbad, Calif. – March 11, 2013: Percepta Associates announces the launch of its Fluorescent Imaging Life Science Dashboard™ market research report revealing Life Technologies (including Molecular Probes and Invitrogen brands), Abcam and BD Biosciences as leading suppliers across various segments. Market segments analyzed in this report…
Percepta: So, as the Editor of the Life Science Dashboards™ tell us what you have been working on lately.
SK: Well, we are going through some format changes to the Dashboard, including updating the brand and look and feel for 2013, and we’ve also improved the structure of the content somewhat. We’ve just completed a month-long audit of some of…read more >
BD Biosciences, EMD Millipore, Life Technologies, Meso Scale Discovery and R&D Systems Emerge as Market Leaders in Relatively Stable, Immunoassay Research Market – Revealed in New Life Science Dashboard™ from Percepta Associates
However, GE/Amersham and Thermo Fisher Scientific Prevail for Certain Chemiluminescent ELISA Segments.
CARLSBAD, Calif.–(BUSINESS WIRE)–Today Percepta Associates launched its Quantitative Immunoassay Life Science Dashboard™ market research report revealing BD Biosciences, EMD Millipore, Life Technologies, Meso Scale Discovery and R&D Systems as leading suppliers in the immunoassay market which includes: colorimetric, chemiluminescent and fluorescent ELISAs, as well as electrochemiluminescence and bead-based…read more >
If you are looking for ways to communicate with researchers that identify themselves as immunology researchers, some of Percepta’s latest data suggests the popularity of various information sources spans a pretty broad spectrum. Search engines still rank high as a place immunologist look for product information. Also popular are peer recommendations, journal citations and company web sites, with more…read more >
As has been shown again and again, seemingly homogeneous cell populations often consist of more than one cell type, which can confound research results. Single-cell research offers a bottom-up approach to circumventing such unwanted cellular heterogeneity. As a testament to its potential promise, the NIH has committed ~$90 million over 5 years to single cell analysis research. At Percepta,…read more >